BOSTON, June 17, 2021 /PRNewswire/ -- Artemis Capital
Partners ("Artemis"), a Boston-based private equity firm focused
exclusively on partnering with differentiated industrial technology
companies, completed the successful sale of its portfolio company,
BioDot ("the Company") to ATS Automation Tooling Systems Inc. (TSX:
ATA).
Since its founding in 1994, BioDot has become an undisputed
leader in the development of automated, high-throughput, ultra-low
volume liquid handling systems for mission-critical applications.
With a unique patent portfolio in ultra-low volume dispensing and
novel applications, BioDot delivers testing and manufacturing
solutions for its customers globally. From R&D to
high-throughput point of care assay production, BioDot continues to
innovate and partner across the biotechnology, diagnostic,
industrial, life science, and medical device end markets.
BioDot achieved substantial growth since Artemis' acquisition in
March 2020. The Company's evolution
in commercial strategy, technological innovation, and market
tailwinds propelled BioDot over the past year. The BioDot
partnership is the latest example of Artemis capitalizing on one of
their core theses - lab automation and diagnostics. A combination
of revamped strategy and a committed team were imperative to
BioDot's success.
Peter Hunter, Founder and
Managing Partner of Artemis and Chairman of BioDot, commented on
the transaction: "We're very proud of the BioDot team and their
growth over the past year. The team's unwavering dedication to
quality, customers, and innovation has made BioDot a leader in
precise, ultra-low volume fluid dispensing in the point-of-care and
clinical diagnostics end-markets. It was a great partnership from
day one."
Anthony V. Lemmo, CEO of BioDot,
echoed the same sentiment: "Our partnership with the Artemis team
was pivotal to our strategic growth since the acquisition. We
believe that we have a great foundation for our next chapter, and
we are thrilled with the outcome."
Baird was the financial advisor and Morgan Lewis was the legal advisor for
Artemis.
About BioDot
Founded in 1994, BioDot manufactures premium non-contact
and quantitative fluid dispensing systems. Combined with its
expertise in lamination, cutting, and assembly, its wide range of
platforms serve BioDot's customers from R&D through high-volume
manufacturing in the industrial, diagnostic, life science, and
medical product markets. Based in Irvine,
California, BioDot has international offices to service a
variety of industries in every nation. Its long-lasting
relationships with customers are built on precision products and
quality service around the world. Visit the company's website at
https://www.biodot.com for more details.
About Artemis
Founded in 2010, Artemis is a Boston-based private equity firm focused on
acquiring and growing manufacturers of differentiated industrial
technologies, including analytical and lab instrumentation. Artemis
seeks to partner with companies that have strong established
management teams, outstanding engineering capabilities, unique
products, and expanding niche markets. For more information on
Artemis, please visit: www.artemislp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/artemis-announces-sale-of-its-portfolio-company-biodot-to-ats-301314886.html
SOURCE Artemis Capital Partners